SQI Diagnostics Inc. announced two new product launches within the imawareTM family of at-home tests by its partner, Microdrop. The new tests, which are now available for purchase, measure markers for rheumatoid arthritis and a test to monitor already-diagnosed celiac disease patients, a complement to the previously announced celiac screening test. As a follow-up to the imawareTM celiac screening test introduced last month, Microdrop has launched a celiac disease monitoring service, which allows someone to purchase a subscription to be continuously monitored, all at-home, to determine if their diet and treatment is effective and sustaining. These tests will be run using SQI's proprietary test kits and automated analysis systems. Run on SQI's automated systems, the imawareTM at-home testing product portfolio, for which SQI is the exclusive provider, addresses a current unmet need in the market. The effectiveness of the imawareTM tests have been validated by top opinion leaders and celiac and autoimmune medical doctors.